Inari Medical Inc. (NARI)
NASDAQ (NGS) NASDAQ (NGS) Primary 
The Schall Law Firm Motivates Investors Who Have Experienced Losses In Inari Medical Inc To Reach Out As It Starts An Inquiry
LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Inari Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / July 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI
NEW YORK, NY / ACCESSWIRE / July 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / July 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / July 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
The Schall Law Firm Urges Shareholders Who Have Endured Losses In Inari Medical Inc To Make Contact As It Commences A Probe
LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Investors in Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Did Inari Medical (NARI) Buy Sales? Investor Lawsuit Claims Kickbacks Fueled Revenue - Hagens Berman
Contact Hagens Berman by July 12, 2024 Deadline to Join Class Action Against Inari Medical (NARI) SAN FRANCISCO, CA / ACCESSWIRE / July 5, 2024 / Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 24, 2022 - Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: [email protected] 844-916-0895 Inari Medical Class Action: Inari Medical, Inc. (NASDAQ: NARI), a leading medical device manufacturer, finds itself embroiled in a complex legal battle as the U.S. Department of Justice (DOJ) intensifies its scrutiny.
Levi & Korsinsky Notifies Shareholders of Inari Medical, Inc.(NARI) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Shareholders of Inari Medical, Inc.(NARI) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. - NARI
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Inari Medical, Inc. ("Inari" or the "Company") (NASDAQ:NARI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI
NEW YORK, NY / ACCESSWIRE / July 4, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
